Risk of cardiac-related mortality in stage IIIA-N2 non-small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database.

Xin SunYu MenJianyang WangYongxing BaoXu YangMaoyuan ZhaoShuang SunMeng YuanZeliang MaZhouguang Hui

Published in: Thoracic cancer (2021)

With a median follow-up of 25 months, no significant differences were found in cardiac-related mortality between the PORT and Non-PORT groups in stage IIIA-N2 NSCLC patients.

Keyphrases

end stage renal disease
risk factors
cardiovascular events
small cell lung cancer
left ventricular
chronic kidney disease
newly diagnosed
ejection fraction
public health
peritoneal dialysis
prognostic factors
type diabetes
emergency department
minimally invasive
adverse drug
drug induced